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1. Introduction 
Diseases of the colon and rectum produce a large burden of morbidity and mortality. 
Inflammatory bowel disease (IBD), such as Crohn’s disease and ulcerative colitis, affects as 
many as 1.4 million people in the United States and 2.2 million people in Europe and leads 
to significant utilization of healthcare resources (Loftus, 2004). Crohn’s disease (CD) is a 
chronic inflammatory disease that can affect the entire gastrointestinal tract from mouth to 
anus, and typically manifests itself with abdominal pain, diarrhea, and weight loss, as well 
as intestinal strictures, obstruction, perforation, or fistulae formation. CD most often 
manifests in the second to third decade of life. The usual disease course is periods of 
abdominal pain and diarrhea alternating with relatively asymptomatic periods. Over time, 
the symptomatic periods become longer, more frequent, and more severe. Ulcerative colitis 
(UC) is limited to the colon and occasionally the terminal ileum, and typically presents with 
diarrhea, passage of mucus, and rectal bleeding. UC is also most commonly diagnosed in 
patients younger than 30 years of age. IBD and colorectal cancer (CRC) are intimately 
linked, as long-standing IBD leads to an increasing risk for CRC over time. In patients with 
UC, the risk for CRC begins to increase after approximately 10 years of disease. The 
estimated risk of CRC is 25% after 25 years with the disease, 35% at 30 years, 45% at 35 
years, and 65% at 40 years (reviewed in Townsend, 2008).  
CRC is the third most commonly diagnosed cancer and the third-leading cause of cancer-
related death in the United States in both men and women (American Cancer Society, 2011). 
In 2010, the American Cancer Society estimated that there were 142,579 new cases of CRC 
and 51,370 deaths attributed to this disease in the US (National Cancer Institute, 2011). The 
incidence of CRC is rising in many countries, in part because a western-style diet is being 
widely adopted (Center et al., 2009). CRC is currently the fourth leading cause of cancer 
deaths in the world (World Health Organization, 2011).  
IBD and CRC are active areas of research, and a number of useful animal models of these 
diseases have been generated. Some of the most widely studied are rodent models, 
including various rat and mouse models. Mouse models are particularly attractive. Mouse 
genetics have been extensively studied, and there is a detailed knowledge base describing 
hundreds of inbred mouse strains as well as a variety of transgenic, knockout, and knockin 
models (reviewed in Rosenberg et al., 2009). Both genetic and chemically induced models of 
IBD and CRC have been validated (reviewed in Kanneganti et al., 2011; Rosenberg et al., 
2009). These models are continually used to more fully understand the natural history of 
colonic diseases as well as test strategies for prevention and treatment. See Table 1 for an 
overview of genetic and chemically induced mouse models of IBD and CRC. 
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Models of Inflammatory Bowel Disease 
Genetic
Model 
Human 
Disease 
Mechanism Phenotype 
SAMP-Yit CD High IFN-Ǆ production Spontaneous terminal 
ileitis, occasional 
perianal ulcers and 
fistulae 
C3H/HejBir UC Increased IFN-Ǆ and IL-2 
production 
Spontaneous ileocecal 
and right-sided colonic 
ulcers and crypt 
abscesses 
TNFΔARE/TNF 3’ UTR-/- CD Increased constitutive 
and inducible TNF 
Polyarthritis and 
transmural intestinal 
inflammation 
T-cell receptor-ǂ-/- UC Increased aberrant TH2-
type T-cells producing 
IL-4 
Pancolitis with soft 
stools 
STAT4 transgenic UC Overproduction of 
STAT-4, leading to CD4+ 
T-cell production of 
TNF-ǂ and IFN-Ǆ 
Severe transmural colitis 
STAT3 deficient CD Disruption of STAT3 in 
macrophages and 
neutrophils, decreased 
IL-10 
Enterocolitis with high 
incidence of colorectal 
adenocarcinomas 
IL-10-/-/CRF2-4 deficient CD Decreased IL-10 with 
increased IL-12 and TNF-
ǂ, loss of downregulation 
of TH1-type T cells, NK 
cells, macrophages 
Chronic enterocolitis 
with lesions in 
duodenum, proximal 
jejunum, and ascending 
colon primarily 
IL-2 -/-/IL-2 receptor ǂ-/- UC Decreased IL-2 (key 
regulatory immune 
cytokine) 
Pancolitis with ulcers 
and wall thickening, 
crypt abscesses, mucin 
depletion, and epithelial 
dysplasia 
IL-7 transgenic UC Initial IL-7 increase, then 
IL-7 deficiency 
Initial acute colitis, 
followed by chronic 
colitis with proctoptosis 
and anal bleeding 
CD4+CD45RBHi T-cell 
transfer 
UC Decreased IL-10, 
increased IFN-Ǆ 
Diarrhea, weight loss, 
transmural colonic 
inflammation, and death 
Heat shock protein 60-
specific CD8+ T-cell 
transfer 
CD Presentation of bacterial 
protein on MHC class 1 
with action of TNF-ǂ 
Severe small intestinal 
inflammation, death 
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Model 
Human 
Disease 
Mechanism Phenotype 
A20 deficient CD Lack of inhibition of 
TNF-induced NFκB 
activity 
Intestinal inflammation, 
cachexia, death 
IKK-Ǆ (NEMO)/IKKǂǃ 
deficient 
UC Complete shutdown of 
NFκB signaling, leading 
to massive inflammatory 
cell infiltration 
Severe chronic pancolitis 
MDR1 deficient UC Spontaneous 
inflammatory response 
triggered by intestinal 
bacterial flora 
Intestinal inflammation 
Keratin 8-/- UC Primary intestinal 
epithelial cell defect 
leading to inflammation 
from intestinal bacterial 
flora 
Colitis and colonic 
hyperplasia 
Double negative  
N-cadherin 
transgenic/chimeric 
IBD Disrupted intestinal 
mucosal barrier leading 
to inflammation from 
contact with intestinal 
bacterial flora 
Chronic inflammation in 
chimeric regions of 
intestinal epithelium 
Chemical 
Model 
Human 
Disease 
Mechanism Phenotype 
Acetic acid UC Enema; epithelial 
inflammation and 
damage 
Epithelial necrosis and 
edema extending from 
lamina propria to as deep 
as muscularis layer 
Iodoacetamide UC Enema; sulfhydryl 
blocker that decreased 
amount/action of 
protective sulfhydryl 
groups 
Diarrhea, dilation, 
adhesions, mucosal 
erosions to deep 
ulcerations, inhibited 
weight gain 
Indomethacin CD In diet; inhibition of 
protective prostaglandin 
synthesis (PGE1, PGE2, 
prostacyclin) 
Ulceration and 
transmural inflammation 
of mid-small intestine 
Trinitrobenzene sulfonic 
acid (TNBS) 
UC Enema; haptenization of 
colonic autologous or 
microbial proteins 
making them 
immunogenic – delayed 
hypersensitivity 
response 
Acute and chronic colitis 
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Model 
Human 
Disease 
Mechanism Phenotype 
Oxazolone UC Enema; haptenization of 
colonic autologous or 
microbial proteins 
making them 
immunogenic – delayed 
hypersensitivity 
response 
Distal colitis 
Dextran sodium sulfate 
(DSS) 
UC Drinking water; directly 
toxic to epithelial cells in 
basal crypts 
Colitis with bloody 
diarrhea, ulcerations, 
granulocytic infiltration, 
weight loss, shortening of 
intestines 
Models of Colorectal Cancer 
Genetic 
Model 
Human 
Disease 
Mechanism Phenotype 
ApcMin/+ mutations FAP Truncating mutations of 
Apc (codons 850, 716, 
1638, and others) 
Multiple small intestinal 
adenomas 
Mismatch repair gene 
mutations (Msh2, Msh3, 
Msh6, Mlh1, Mlh3) 
HNPCC Mutations in various 
mismatch repair genes 
Adenomas and 
adenocarcinomas of 
entire GI tract, some 
mutations prone to 
lymphomas, squamous 
or basal cell carcinomas 
ǃ-catenin stabilizing 
mutations 
FAP Stabilization of ǃ-catenin 
leading to activation of c-
Myc and cyclin D  
Hundreds of small 
intestinal adenomas 
Smad3-/- CRC Loss of cellular signaling 
protein in TGF-ǃ 
pathway 
CRC with occasional 
metastasizes to regional 
lymph nodes 
K-rasV12G CRC Activation of mutated K-
ras 
Colorectal tumors 
ranging from 
microadenomas to 
invasive 
adenocarcinomas 
without metastasis 
Muc2-/- IBD-
related 
CRC 
Mutation of Muc2, which 
controls gastrointestinal 
mucin 
Adenomas and 
adenocarcinomas in the 
intestines without 
distant metastasis, rectal 
cancers
IL-2-/-/ 
ǃ2-microglobulin-/-  
UC-
related 
CRC 
Chronic inflammation 
from decreased IL-2 and 
ǃ2-microglobulin 
Adenocarcinoma of 
colon and rectum 
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Model 
Human 
Disease 
Mechanism Phenotype 
IL-10-/- CD-
related 
CRC 
Chronic inflammation 
with decreased IL-10 in 
setting of colonic 
bacterial infection 
Adenocarcinomas 
without metastasis or 
mutations in K-ras, p53, 
Apc, and Msh genes 
RAG2-/- Inflam-
mation- 
related 
CRC 
Induced with Helicobacter 
hepaticus infection 
Intestinal dysplasia, 
tubular adenomas, 
 and adenocarcinomas  
of cecum and colon 
RAG2-/-/Tgfβ1-/- Colitis-
related 
CRC 
Downregulation of TGF-
ǃ signaling pathway 
Locally invasive 
adenocarcinomas in 
cecum and colon 
TCRǃ-/-/p53-/- UC-
related 
CRC 
Dysregulation of T-cell 
function with lack of p53 
tumor suppression 
Dysplasia and 
adenocarcinoma of 
ileum and cecum 
Gpx1-/-/Gpx2-/- Ileo-
colitis-
related 
CRC 
Loss of glutathione 
peroxidase 1 and 2 
leading to peroxidative 
stress with  
bacteria-associated 
inflammation 
Dysplasia, 
adenocarcinomas, signet 
ring cell carcinoma seen 
in ileum and colon 
Gǂi2-/- UC-
related 
CRC 
Loss of G protein 
function 
Colonic ulcerations, 
atypical colonic glands 
Conditional Apc-/- Meta-
static 
CRC 
Floxed Apc mutation 
activated by adenovirus-
delivered cre 
recombinase 
Invasive colorectal 
cancers with metastases 
to liver 
Xenografts Meta-
static 
CRC 
Implantation of human 
CRC tumor cells in 
immunocompromised 
mice 
Invasive CRC with 
metastases 
Chemical 
Model 
Human 
Disease 
Mechanism Disease/Pathology 
1,2-dimethylhydrazine 
(DMH)/ 
Azoxymethane 
(AOM)/methyl- 
azoxymethanol (MAM) 
CRC Intraperitoneal injection; 
procarcinogens  
activated to DNA-reactive 
products which alkylate 
molecules in liver and 
colon 
Distal colon tumors 
Heterocyclic amines 
(PhIP, IQ, etc.) 
CRC In diet; mutagenic and 
tumorigenic agents in 
broiled food 
Colon cancers, 
mammary tumors, 
prostate tumors 
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Model 
Human 
Disease 
Mechanism Phenotype 
Aromatic amines (DMAB) CRC Subcutaneous injection; 
tumorigenic agent 
Adenomas, invasive 
adenocarcinomas of 
colon and mammary 
glands, salivary gland 
sarcomas, skin and ear 
squamous cell 
carcinomas, stomach 
squamous cell 
papillomas, 
sarcomas/lymphomas/ 
urothelial carcinomas of 
bladder 
Alkylnitrosamides 
(MNNG, MNU) 
CRC Enema; direct alkylating 
agent 
Sessile and polypoid 
adenomas and 
adenocarcinomas, rare 
metastases 
Table 1. Mouse models of inflammatory bowel disease (IBD) and colorectal cancer (CRC). 
This table provides a summary of currently utilized mouse models of IBD and CRC. In 
addition to these singly listed models, various models are often combined, e.g. DSS and 
AOM or DSS in ApcMin/+ mice. (Reviewed in Hung, 2010; Jurjus et al., 2004; Kanneganti et 
al., 2011; McCart et al., 2008; Rosenberg et al., 2009; Taketo, 2006; Taketo & Edelmann, 2009; 
Wirtz & Neurath, 2007) 
Abbreviations: CD: Crohn’s disease; IFN: interferon; UC: ulcerative colitis; IL: interleukin; 
TNF: tumor necrosis factor; UTR: untranslated region; STAT: signal transducer and 
activating transcription; MHC: major histocompatibility complex; IBD: inflammatory bowel 
disease; Apc: Adenomatous polyposis coli; Min: Multiple intestinal neoplasia; FAP: familial 
adenomatous polyposis; HNPCC: hereditary nonpolyposis colon cancer; CRC: colorectal 
cancer; TGF: transforming growth factor; PhIP: 2-amino-1-methyl-6-phenylimidazo[4,5-
b]pyridine; IQ: 2-amino-33-methylimidazo[4,5-f]quinoline; DMAB: 3,2’-dimethyl-4-
aminobiphenyl; MNNG: N-methyl-N’-nitro-N-nitrosoguanidine; MNU: methylnitrosourea 
Although murine models of colonic diseases are powerful, one limitation has been the large 
number of animals needed to complete an adequately powered study. Traditionally, 
experiments had a cross-sectional design in which mice from different groups were 
sacrificed at a set point in time, and the intestinal tract was examined at necropsy. This 
limitation has been overcome with recent advances in technology. A variety of imaging 
tools have been developed, allowing longitudinal assessment of the large intestine in 
animal models. Currently utilized methods include computed tomography (CT), magnetic 
resonance imaging (MRI), and direct visualization with colonoscopy. The ability to 
serially assess changes in the large intestine allows more detailed information about 
diseases to be gathered with a smaller cohort of experimental animals (Durkee et al., 
2009). 
This chapter will discuss the use of colonoscopy in rodent models of IBD and CRC. The 
method of performing colonoscopy in experimental animals will be described as well as the 
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various adjuncts that can be combined with colonoscopy to enhance the amount of data that 
can be gathered. The strengths and limitations of colonoscopy will be discussed. Finally, 
colonoscopy will be compared and contrasted with alternative methods of imaging the large 
intestine, such as CT and MRI. 
2. Colonoscopic technique 
Colonoscopy is the gold standard for screening, evaluating, and potentially treating diseases 
of the colon, including IBD and CRC. In humans, this procedure in its current manifestation 
involves inserting a flexible endoscope through the anus, using compressed gas to insufflate 
the colon, and carefully advancing to the cecum and terminal ileum. The camera at the tip of 
the colonoscope displays images on a monitor. As the colonoscope is withdrawn, the colonic 
mucosa is carefully inspected. The colonoscope has channels allowing insertion of various 
tools (biopsy forceps, snare cautery, needles for injection, etc.), allowing collection of 
biopsies, removal or destruction of potentially neoplastic lesions, or other interventions.  
The power of this tool was recognized by researchers, and various groups have attempted to 
adapt it for use in animal models of IBD and CRC. Colonoscopy has been successfully 
adapted for use in rat models. Using modified bronchoscopes (Hull et al., 1990) or other 
small-caliber flexible endoscopes (Haughn et al., 2006), total colonoscopy of the rat has been 
performed successfully, as well as other variations of this procedure (Zhang et al., 1994). 
Colonoscopy in mice was first attempted with a pediatric cystoscope with good results, 
although because of anatomic and instrumental limitations, the entire colon to the cecum 
could not be visualized (Huang et al., 2002). High resolution endoscopy can now be 
performed with colonoscopes designed specifically for work with rat and mouse models of 
colonic disease.  
Becker, Fantini, and Neurath published a description of high-resolution colonoscopy in live 
mice (Becker et al., 2006). This procedure is followed by our lab with modifications. We use 
the Coloview miniendoscope system (Karl Storz, Tuttlingen, Germany), which includes an 
colonoscope (0 degree, 1.5 mm, rigid) with operating sheath and light source, video monitor, 
and camera with the capability to record video as well as obtain still images during 
colonoscopy, and a small air pump. See Figure 1 for an illustration of the set-up that  we use. 
The mouse is anesthetized with inhaled isoflurane, and is placed ventral-side down on an 
operating platform. An oral gavage needle on a syringe is used to introduce Dulbecco’s 
phosphate buffered saline (PBS) via the anus as a pre-procedure enema for bowel 
preparation to ensure adequate visualization. This step can be repeated as needed to ensure 
adequate clearing of colonic contents prior to colonoscopy. We do not fast the mice prior or 
provide any additional bowel preparation other than the PBS enema, and we are nearly 
always able to obtain adequate visualization of the colonic mucosa. Note that we initially 
did fast the mice and provide oral NuLytely (an osmotic bowel preparatory agent), but we 
found that this step was unnecessary to obtain excellent visualization of the colon. The PBS 
enema also serves as lubrication prior to insertion of the colonoscope. The air pump is 
attached to the colonoscope to provide insufflation of the colon for adequate visualization 
throughout the procedure. Figure 2 shows an experimental mouse undergoing colonoscopy 
while under general anesthesia. 
The mouse colon has relatively simple geometry, unlike the tortuosity that is associated with 
the human colon. The mouse colon extends in a fairly straight line for approximately 4 cm 
cranially from the anus toward the left kidney, where it turns approximately 90 degrees and 
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Fig. 1. Colonoscopy set-up. 
On the left is the portable tower containing the monitor, light source, camera, and computer 
used for recording and saving videos and still images. On the right is the benchtop set-up 
for colonoscopy in mice. A: air pump for insufflation of the colon. B: biopsy forceps. C: 
colonoscope with working sheath in place, connected to air pump (blue tube) and light 
source (gray cable). D: nose cone for administration of inhaled anesthetic attached to 
operating platform. E: PBS for pre-operative enemas. F: flexible catheter to be inserted 
through working channel of colonoscope with scale markings for standardization of images 
and in situ measurments. G: gavage needle attached to syringe with PBS for administration 
of pre-procedure enemas. H: soft brush for cleaning lens of colonoscope. 
extends across the upper abdominal cavity, connecting with the generous mouse cecum 
near the right kidney. The colonoscope is carefully introduced into the anus and advanced 
about 4 cm, or until the first area of curvature of the colon (corresponding to the splenic 
flexure) while observing progress on the monitor. We typically record video and obtain still 
images as the colonoscope is slowly withdrawn. The entire procedure takes approximately 5 
minutes or less. The mouse is then allowed to awake from anesthesia. Figure 3 demonstrates 
the appearance of normal mucosa on colonoscopic examination. 
This procedure is very well tolerated by experimental animals. However, some 
complications should be mentioned. Mice that are ill or moribund may not tolerate general 
anesthesia, so careful assessment of the animal’s overall state of health should be made prior 
to the procedure. The wall of the colon is quite thin, so care must be taken not to cause 
perforation. Perforation can occur at the time of enema with the gavage needle or with the 
colonoscope. This injury is most likely to happen at the time of insertion, as inadvertent 
trauma to the colon becomes less likely under direct visualization. Care needs to be taken 
during insufflation as two potential complications could occur. Over-insufflation can cause 
air to travel throughout the length of the gastrointestinal tract to the point that gastric 
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Fig. 2. Mouse colonoscopy. Image of colonoscopy being performed in a living mouse under 
general anesthetic. Insufflation is provided by air via the blue tube shown above. The 
amount of insufflation is controlled by placing a finger over the opposite opening of the 
working sheath. The graduated flexible measuring catheter is seen protruding from the 
working channel of the colonoscope. 
 
 
Fig. 3. Normal intestinal muscosa. Colonoscopy image showing normal intestinal mucosa. 
contents are forced up the esophagus and lead to aspiration. In addition, over-distention of 
the intestines can lead to respiratory compromise if the abdomen becomes sufficiently 
distended to affect diaphragmatic function. Such complications are rare for experienced 
operators. Incorporation of additional procedures, such as biopsies, during the colonoscopy 
has the potential to increase complications. Reported mortality rates range from <1% to 2.9% 
(Becker, 2005; Hensley, 2009). 
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2.1 Experimental uses and adjuncts 
Colonoscopy allows visual grading of colitis and repeat assessment over time. Both video 
and still images can be obtained and stored for analysis. Scoring systems of colitis have been 
developed and published. The criteria that can be easily visualized include the thickness of 
the colon, changes in vascular pattern, presence of fibrin, mucosal surface granularity, and 
stool consistency (Becker et al., 2005, 2006). In order to better visualize crypt patterns and 
detect aberrant crypt foci, which some consider early neoplastic lesions, the colonic 
epithelium can be stained with a 1% solution of methylene blue and then examined with the 
colonoscope. By performing this procedure, termed chromoendoscopy, according to 
previously published protocols, aberrant crypt foci can be identified that would be 
undetectable without staining, potentially enabling early recognition of pre-neoplastic 
lesions prior to tumor formation (Becker et al., 2005, 2006). 
Colonic tumors that are at or distal to the splenic flexure (approximately the distal 3-4 cm of 
colon) can be followed serially by colonoscopy. This allows study of the natural history of 
tumors. Figure 4 demonstrates the progression of a single tumor in one mouse over the 
course of four months. Several groups have published methods of visually grading the size of 
tumors assessed on colonoscopy. Becker and colleagues have published a method of scoring 
tumor size relative to the lumen of the insufflated colon (Becker et al., 2005). However, the still 
images must be taken at a consistent distance from the tumor and the colon must be 
consistently insufflated in order for meaningful comparisons to be made between time-points. 
Hung and colleagues describe using the relative lumen size of a fully insufflated colon as a 
normalization factor when obtaining images (Hung et al., 2010). Various tools can be inserted 
through the working channel of the colonoscope to provide a visual frame of reference and 
guide for standardization of view. A tool that has a known diameter and has markings 
 
 
 
Fig. 4. Intestinal tumor development. Colonoscopy images showing the development of an 
intestinal tumor in a single mouse over time. Panel A: Early neoplastic lesion. Panel B: Small 
flat tumor approximately 1 month after image in A. Panel C: The tumor has continued to 
increase in size and is now pedunculated after 10 weeks. Panel D: The same tumor after an 
additional 4 weeks, with noticeable increase in size. 
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at set intervals can be used to quantify the size of tumors seen on endoscopy. Hensley and 
collegues have described a method using biopsy forceps. The 1-mm-diameter flexible metal 
biopsy forceps was inserted through the working channel of the colonoscope and advanced 
until it was visible in the field of view adjacent to the tumor. Still images were taken in this 
configuration, and the images were analyzed using a specifically written software program 
that allowed estimation of the tumor size by performing geometric reconstruction based on 
the position of the cylindrical forceps relative to the adenoma (Hensley et al., 2009). We use 
a flexible embolectomy catheter that has been marked at 1 mm intervals to standardize our 
images (see item F in Figure 1).  
Biopsy forceps are available from Karl Storz which can be passed through the instrument 
channel of the operating sheath. Using these small, flexible forceps, tissue can be taken from 
tumors or areas of colon wall thickened by colitis. Figure 5 demonstrates the endoscopic 
biopsy of a single tumor in an experimental mouse. Care must be taken, however, not to 
biopsy normal colonic mucosa as the colon wall in the mouse is quite thin, and biopsies of 
this tissue would have an unacceptably high rate of perforation. Biopsies can be snap frozen 
with liquid nitrogen, placed in stabilizing media, or fixed in formalin for 
immunohistochemistry, molecular analysis, hematoxylin-eosin staining, or other 
biomolecular studies (Becker et al., 2005, 2006). In addition, Becker and colleagues have 
described directly injecting individual tumors with reagents via a small-gauge needle under 
endoscopic guidance. They inserted a 26-gauge needle mounted on a small tube through the 
working channel of their endoscope and injected fluorescein isothiocyanate into a tumor 
under direct visualization. On necropsy, the tumor was dissected free from the mouse colon 
and cryosections were analyzed by immunofluorescence, which showed fluorescein 
isothiocyanate throughout the tumor (Becker et al., 2005). 
 
 
Fig. 5. Colonoscopic tumor biopsy. This series of images shows the steps in obtaining a 
biopsy of a tumor during colonoscopy. Panel A: insertion of biopsy forceps. Panel B: 
opening biopsy forceps. Panel C: grasping tumor with forceps. Panel D: bleeding from the 
tumor after biopsy ensures that adequate tissue was obtained. 
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An exciting recent development in small animal research is the use of bioluminescent and 
fluorescent molecules to image diverse cellular, molecular, and tissue processes. Fluorescent 
probes have been developed for specific antibodies, protein ligands, and other substrates 
(see Citrin & Camphausen, 2004, and Luker & Luker, 2008, for reviews of these techniques). 
These technologies can be combined with endoscopy to provide real-time imaging of 
fluorescent probes to detect perfusion and protease activity, as was demonstrated by 
Funovics and colleagues with their miniaturized multichannel near-infrared endoscope. 
They designed an endoscope that also allowed simultaneous fluorescent imaging of murine 
colonic tumors, allowing them to superimpose fluorescent perfusion and protease activity 
over white-light images (Funovics et al., 2003). This method has been shown to be useful for 
imaging adenomas as well as adenocarcinomas (Funovics et al., 2006). Hung and colleagues 
have reported using protease-activated synthetic probes to identify colonic lesions with 
near-infrared colonoscopy (Hung et al., 2010). Fluorescent probes such as this may prove 
useful in identifying early neoplastic lesions that are not easily visible on white-light 
endoscopy or in monitoring action of novel preventive or therapeutic agents. 
3. Strengths and limitations 
3.1 Strengths 
Utilizing colonoscopy in mice has a number of distinct advantages. One of the most striking 
is the ability to monitor changes in colonic pathology over time. Within the same mouse, the 
initiation and evolution of colitis as well as response to treatment can be followed. Similarly, 
tumors can also be followed longitudinally, potentially from their earliest manifestation and 
as they progress from a benign to invasive state over time. This allows the study of a single 
tumor in a single mouse over time. Researchers are able to gain valuable information about 
the morphology of the tumor, i.e. flat vs. pedunculated, smooth vs. lobulated, as well as 
visualize vascular patterns in and around the tumor mucosa. Small sessile lesions that are 
missed on other in vivo imaging modalities can be easily identified on colonoscopy. 
Additionally, tissue can be obtained by biopsy at multiple time points for histology as well 
as for molecular analysis. Prior to use of colonoscopy, in order to study the natural history 
of colonic disease, multiple mice would have to be sacrificed at various time points, and the 
results of the examinations aggregated. With colonoscopy, diseases such as colitis or colon 
neoplasm can be studied at multiple time points in the same mouse, allowing the mouse to 
serve as its own control, thereby eliminating variation owing to genetic and environmental 
effects. In addition, being able to serially study the same mouse greatly reduces the number 
of mice needed in order to design an adequately powered study (Becker et al., 2005, 2006; 
Durkee et al., 2009; Hensley et al., 2009). 
Colonoscopy in mice is a relatively simple and cost-effective procedure that is well-tolerated 
by experimental animals. Colonoscopy is portable and relatively inexpensive, although 
there is an initial cost to purchase the equipment. Other methods of imaging murine colonic 
disease, such as microCT colonography or MRI, require more expensive scanners as well as 
a dedicated space for the necessary equipment. 
3.2 Limitations 
There are significant limitations of colonoscopy that deserve discussion. Although 
colonoscopy is a relatively safe procedure, there is still an associated morbidity and 
mortality, as discussed earlier in the section on colonoscopic technique. There are also 
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limitations inherent in the procedure itself. The quality of the data gathered by colonoscopy 
is operator-dependent, and there is a learning curve before the scope can be safely and 
effectively used. The images that are obtained are two-dimensional, so estimating the 
volume of a tumor is difficult. Most significantly, current technology only allows 
visualization of the distal half (3-4 cm) of the mouse colon. A flexible colonoscope that can 
be used safely in mice is unavailable, which means that any lesions proximal to the splenic 
flexure are inaccessible in vivo. 
4. Comparison to other imaging modalities 
4.1 Micro-computed tomography colonography 
A number of methods for imaging the colons of experimental mice are becoming available. 
Micro-computed tomography (mCT) colonography is a useful tool for examining colonic 
disease, in particular neoplasia. Also known as virtual colonoscopy, this modality uses x-
rays to image the colon and surrounding tissues, and can be used to generate either two-
dimensional or three-dimensional reconstructions of individual tumors. Virtual colonoscopy 
has been shown to be an accurate screening tool for detecting colon polyps in humans (Kim 
et al., 2007), making its utilization in murine experiments very clinically relevant. Several 
groups have modified this technology for use in the mouse, allowing longitudinal study of 
mouse models of colonic disease (Durkee et al., 2010). Choquet and colleagues have used 
mCT with luminal and intraperitoneal contrast to detect azoxymethane-induced cecal 
heterotypia and colon tumors. They identified 9 of 9 areas of heterotypic thickened cecal 
wall and 11 of 11 colon tumors with no false positives (Choquet et al., 2007). Pickhardt and 
colleagues showed that by modifying feed and providing bowel preparation with an 
osmotic agent, mCT could detect colonic tumors ≥2mm in maximum diameter with 93.3% 
sensitivity and 92% specificity (Pickhardt et al., 2005). These investigators went on to 
demonstrate tumor volume measurements by mCT were accurate predictors of actual tumor 
size (Durkee et al., 2008). Good quality mCT scans had a mean standard deviation in tumor 
volume measurements of 8%, meaning that changes in tumor volume of >16% are detectable 
with a 95% confidence interval. Thus, colon tumors can be reliably identified and followed 
over time by mCT in order to determine if they grow, regress, or remain static either 
spontaneously or in response to therapy (Durkee et al., 2009). This imaging platform is very 
powerful when testing therapeutic interventions. 
mCT colonography offers several advantages over colonoscopy. This is a non-invasive 
procedure, so there is minimal risk of morbidity or mortality to the experimental animals, 
although general anesthesia and colonic insufflation are not without risk. Current 
technology allows three-dimensional rendering of tumors, allowing accurate measurement 
of volume, as opposed to the size estimates that can be made using flat two-dimensional 
images from colonoscopy (Durkee et al., 2008). Importantly, the entire colon from cecum to 
anus can be assessed by mCT colonography, rather only the distal 4 cm as is currently 
visible on colonoscopy. In addition, extracolonic manifestation of disease, specifically 
metastatic lesions, can be seen on mCT in vivo. 
There are advantages offered by colonoscopy, however. Compared to mCT colonography, 
colonoscopy is faster (an average of 5 minutes versus 20 minutes), requiring less time under 
anesthesia for experimental animals (Durkee et al., 2009). The equipment and set-up for 
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colonoscopy are also less expensive than mCT, both in terms of actual hardware required as 
well as the dedicated space needed for a CT scanner. Colonoscopy is also able to detect 
small or sessile tumors that are not visible on mCT colonography, which relies on the 
contrast between the appearance of colonic contents and tissue structures, and is thus 
unable to detect lesions <2mm or flat lesions. Colonoscopy can also be used to monitor 
colonic inflammation, which is not easily appreciated on mCT colonography. mCT 
colonography does employ ionizing radiation, and the length of the scan currently exposes 
experimental animals to approximately 0.25 Gray, which is to up to 10 times the amount 
used on humans. The effects of this level of radiation on mice are unknown. Finally, 
colonoscopy offers the opportunity to perform additional procedures concurrently under 
direct visualization. mCT colonography does not offer the opportunity to obtain biopsies, 
perform in vivo staining as with chromoendoscopy, or add any of the other adjunctive 
procedures discussed above. 
4.2 Magnetic resonance imaging 
Another imaging modality used to study colonic disease is magnetic resonance imaging 
(MRI). Hensley and colleagues described a protocol whereby the entire colon is visualized 
by MRI. Using this imaging platform, polypoid tumors 1.5 mm in largest dimension could 
be reliably identified, with 17 correctly identified tumors, 2 false negatives, and 2 false 
positives. Volumes of the tumors were estimated from MRI and correlated well with tumor 
weight (Hensley et al., 2004). Young and colleagues were able to accurately measure the 
volume of polypoid colonic tumors at multiple time points (Young et al., 2009). Estimates of 
cross-sectional area made on colonoscopy, MRI, and necropsy were compared by Hensley 
and colleagues, and were found to have a strong correlation (Hensley et al., 2009). In 
addition to colon tumors, numerous investigators have demonstrated that colitis can be 
visualized on MRI. A number of groups have been able to appreciate acute experimentally 
induced colonic inflammation when imaging mice after treatment with dextran sodium 
sulfate, a commonly used agent to model acute colon inflammation in the mouse. Acute 
inflammation seen on MRI was confirmed on histological examination of the colon after 
sacrifice (Larsson et al., 2006; Melger et al., 2007; Mustafi et al., 2010; Young et al., 2009). The 
colon wall thickness, T2-weighted imaging, and quantitative analysis of contrast uptake and 
wash-out were all significantly different in inflamed colons. These studies show that MRI 
colonography is a viable option for longitudinal study of experimentally induced colitis, 
allowing the longitudinal study of inflammatory colon diseases (Larsson et al., 2006; Melger 
et al., 2007; Mustafi et al., 2010; Young et al., 2009). 
MRI colonography offers the same advantages over colonoscopy that mCT colonography 
does with the additional advantage that no ionizing radiation is used. However, there are 
reasons to choose colonoscopy over MRI. MRI colonography requires the use of contrast 
agents, either intravenously, intramuscularly, or rectally; in addition to being difficult to 
administer, the exact effects of these agents on experimental mice are unknown. As with 
mCT, set-up and maintenance of an imaging facility are expensive. MRI is also less than 
ideal for identifying flat tumors when compared to colonoscopy as these are not as readily 
apparent as polypoid tumors. Table 2 compares and contrasts these modalities for imaging 
colon tumors in vivo in mice. 
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Imaging Platform Advantages Disadvantages 
Colonoscopy Quick
Relatively safe for experimental 
animals 
Relatively inexpensive 
Serial examinations 
Direct visualization of colonic 
mucosa 
Visualization of flat or polypoid 
lesions 
Ability to perform in vivo staining 
Ability to obtain tissue biopsies 
Ability to combine with 
fluorescent probes for protease or 
vascular imaging
Occasional mortality in 
experimental animals 
Initial cost of equipment 
Unable to visualize 
proximal to splenic flexure 
Unable to visualize extra-
luminal disease 
2-dimensional images only, 
so difficult to accurately 
assess tumor size and 
volume 
Quality of images 
operator-dependent 
mCT colonography Non-invasive with minimal risk of 
mortality in experimental animals 
Ability to measure tumors in 3 
dimensions, resulting in accurate 
and precise measurements of 
tumor volume 
Ability to image entire length of 
colon 
Visualization of extracolonic 
lesions, i.e. metastases 
More time required for 
procedure 
Ionizing radiation with 
unknown effects 
Expensive 
Inability to identify sessile 
lesions or lesions <2 mm 
Unable to perform 
additional procedures 
(biopsy, staining, etc.) 
MRI colonography Noninvasive with minimal risk of 
mortality 
No ionizing radiation 
Ability to visualize inflammation 
Ability to measure tumors in 3 
dimensions 
Ability to visualize extracolonic 
lesions
Contrast required 
More time required 
Expensive 
Inability to identify small or 
sessile lesions 
Unable to perform 
additional procedures 
Table 2. Comparison of imaging modalities. 
This table compares and contrasts colonoscopy, mCT colonography, and MRI colonography 
for colorectal cancer in mouse models. 
5. Conclusion 
Colonoscopy is a powerful tool for studying pathology in mouse models of colonic disease. 
This is a safe, relatively quick procedure that enables researchers to study the natural history 
of colonic diseases, to visually assess response to therapeutics or interventions, and to obtain 
tissue from living animals. By allowing serial examinations of the colon, it decreases the 
number of mice needed to adequately power a study. Colonoscopy can be combined with 
staining techniques or fluorescent probes to gather data about a variety of cellular, 
molecular, or tissue processes simultaneously. Colonoscopy is comparable to other imaging 
modalities available to study the murine colon, such as mCT or MRI colonography. 
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